eFFECTOR Therapeutics is a company that provides Effector, Health care, Cancer and more. eFFECTOR Therapeutics is headquartered in United States California. eFFECTOR Therapeutics was founded in 2012. and was founded by Davide Ruggero, Kevan Shokat, Kevin Eastwood, Siegfried Reich, Steve Worland. eFFECTOR Therapeutics has a total of 223 patents
Biomedical Advanced Research and Development Authority (BARDA)
[+n]
Related Market Sectors
Cancer Gene Therapy Market
RNA-Targeted Small Molecules
Synthetic Lethality-based Drugs and Targets Market
Manufacturing and Supply Partnering Terms and Agreements
Option and Evaluation Partnership Terms and Agreements
Big Pharma Partnering Terms and Agreements
Clinical Stage Partnering Terms and Agreements
Monoclonal Antibody Partnering Terms and Agreements
[+n]
Download
Innovation Matrix
visualizing technology portfolio of hot application areas and blank areas for eFFECTOR Therapeutics
Time Range:
Overall
Overall
1 year
3 year
5 year
Application Domain L2
Application Domain L2
Application Domain L3
Application Domain L4
High-Tech Industry L1
High-Tech Industry L2
Tech Topic L2
Tech Topic L3
Timeline
Tech Topic L2
Tech Topic L2
Tech Topic L3
High-Tech Industry L1
High-Tech Industry L2
Application Domain L2
Application Domain L3
Application Domain L4
Download
Subsidiary Lists
Subsidiaries with patent applications for eFFECTOR Therapeutics
Sign up to view the full data
Free Trial Now
Download
eFFECTOR Therapeutics Frequently Asked Questions
What is eFFECTOR Therapeutics's industry?
eFFECTOR Therapeutics is in the industry of:Research and Development in the Physical, Engineering, and Life SciencesPharmaceutical and Medicine Manufacturing
What technical fields has eFFECTOR Therapeutics researched?
eFFECTOR is a clinical stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective...